Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920273's PB Ratio is ranked better than 51.72% of 1220
companies
in the Biotechnology industry
Industry Median: 2.9
vs BJSE:920273: 2.69
During the past 12 months, Hubei Yizhi Konjac Biotechnology Co's average Book Value Per Share Growth Rate was 5.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 11.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 14.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 18.40% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Hubei Yizhi Konjac Biotechnology Co was 46.60% per year. The lowest was 11.70% per year. And the median was 19.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hubei Yizhi Konjac Biotechnology Co PB Ratio Related Terms
Hubei Yizhi Konjac Biotechnology Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Yizhi Konjac Biotechnology Co PB Ratio Chart
BJSE:920273 vs VRTX, REGN, RVMD: PB Ratio Comparison
For the Biotechnology subindustry, Hubei Yizhi Konjac Biotechnology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hubei Yizhi Konjac Biotechnology Co PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hubei Yizhi Konjac Biotechnology Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hubei Yizhi Konjac Biotechnology Co's PB Ratio falls into.
Hubei Yizhi Konjac Biotechnology Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) has a PB Ratio of 2.69 as of Aug. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hubei Yizhi Konjac Biotechnology Co and its competitors. This is near median its historical median of 2.56. Over the past decade, Hubei Yizhi Konjac Biotechnology Co's PB Ratio has ranged from 1.17 to 8.21. According to the industry distribution chart, Hubei Yizhi Konjac Biotechnology Co ranks #589 out of 1220 companies in the Biotechnology industry, placing it in the top 48.3%.
Is Hubei Yizhi Konjac Biotechnology Co's PB Ratio too high?
Hubei Yizhi Konjac Biotechnology Co's current PB Ratio of 2.69 is near median its 10-year median of 2.56. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 8.21. The Biotechnology industry median PB Ratio is 2.90. Hubei Yizhi Konjac Biotechnology Co's value of 2.69 is 7.2% below this industry median. Based on the distribution chart, Hubei Yizhi Konjac Biotechnology Co ranks #589 out of 1220 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Hubei Yizhi Konjac Biotechnology Co has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hubei Yizhi Konjac Biotechnology Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hubei Yizhi Konjac Biotechnology Co ranks #589 out of 1220 companies for PB Ratio. This puts Hubei Yizhi Konjac Biotechnology Co in the upper half of its industry. The industry median PB Ratio is 2.90. Hubei Yizhi Konjac Biotechnology Co's value of 2.69 is 7.2% below this benchmark. Historically, Hubei Yizhi Konjac Biotechnology Co's own PB Ratio has ranged from 1.17 to 8.21 over the past decade. While the company's 10-year median is 2.56 vs. the industry median of 2.90, Hubei Yizhi Konjac Biotechnology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.90, based on 1,220 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hubei Yizhi Konjac Biotechnology Co's current PB Ratio of 2.69 is 7.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hubei Yizhi Konjac Biotechnology Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hubei Yizhi Konjac Biotechnology Co's current PB Ratio is 2.69, which is near median its own 10-year median of 2.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Yizhi Konjac Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) is currently considered Fairly Valued. The stock's GF Value™ is ¥19.31, compared to a current price of ¥17.77 — trading 8% below its estimated fair value. The current PB Ratio is 2.69, which is near median its 10-year median of 2.56 and 7.2% below the Biotechnology industry median of 2.90. Hubei Yizhi Konjac Biotechnology Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hubei Yizhi Konjac Biotechnology Co (BJSE:920273), the current PB Ratio is 2.69 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hubei Yizhi Konjac Biotechnology Co (BJSE:920273) Overvalued in 2026?
Based on GuruFocus' analysis, Hubei Yizhi Konjac Biotechnology Co stock appears to be undervalued.
The current stock price of ¥17.77 is trading 8% below its estimated GF Value™ of ¥19.31.
GuruFocus considers Hubei Yizhi Konjac Biotechnology Co to be Fairly Valued.
Key valuation signals for BJSE:920273:
PB Ratio: 2.69 (near median its 10-year median of 2.56)
GF Value™: ¥19.31 vs. price of ¥17.77 (8% below fair value)
Industry Position: 7.2% below the Biotechnology median (#589 of 1220)
No single metric tells the full story. See the BJSE:920273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hubei Yizhi Konjac Biotechnology Co Ltd is a biotechnology enterprise specializing in the deep processing of konjac. It engages in research and development, production, and sales of konjac-intensive processing and konjac-related products. It has three product categories of konjac gum, konjac food, and konjac tools and nearly 66 product series.
76GF Score
Get the complete analysis for BJSE:920273
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920273 has been successfully added to your 
